Challenges of deprescribing and minimizing use of anticholinergic medications
Medications with anticholinergic properties have been consistently associated with a wide range of adverse outcomes for older adults including cognitive impairment, yet these drugs continue to be commonly prescribed for depression, urinary incontinence, irritable bowel syndrome and Parkinson’s disease. In an editorial published in the peer-reviewed journal Frontiers in Pharmacology, co-authors Noll Campbell, PharmD, M.S., and Malaz Boustani, M.D., […]
Challenges of deprescribing and minimizing use of anticholinergic medications Read More »
